3D cell models are revolutionising #drugdiscovery by providing more accurate predictions of drug efficacy and safety. Experts see these trends continuing, but barriers remain to their widespread adoption, partly due to challenges in standardizing protocols and overcoming technical limitations. Learn more about the importance of #3Dbiology, current challenges, and innovative solutions in our blog post: https://hubs.la/Q03K_Qrx0
About us
Molecular Devices is one of the world’s leading providers of high-performance life science technology. We make advanced scientific discovery possible for academia, pharma, and biotech customers with platforms for high-throughput screening, genomic and cellular analysis, colony selection and microplate detection. From cancer to COVID-19, we've contributed to scientific breakthroughs described in over 230,000 peer-reviewed publications. Over 160,000 of our innovative solutions are incorporated into laboratories worldwide, enabling scientists to improve productivity and effectiveness – ultimately accelerating research and the development of new therapeutics. Molecular Devices is headquartered in Silicon Valley, Calif., with best-in-class teams around the globe. Over 1,000 associates are guided by our diverse leadership team and female president that prioritize a culture of collaboration, engagement, diversity, and inclusion. Molecular Devices is proud to be part of Danaher. Danaher’s science and technology leadership puts Molecular Devices’ solutions at the forefront of the industry, so they can reach more people. Being part of Danaher means we can offer unparalleled breadth and depth of expertise and solutions to our customers. Together with Danaher’s other businesses across Biotechnology, Diagnostics and Life Sciences, we unlock the transformative potential of cutting-edge science and technology to improve billions of lives every day. To learn more about how Molecular Devices helps fast-track scientific discovery, visit www.moleculardevices.com.
- Website
-
https://www.moleculardevices.com
External link for Molecular Devices
- Industry
- Biotechnology Research
- Company size
- 1,001-5,000 employees
- Headquarters
- San Jose, CA
- Type
- Public Company
- Founded
- 1983
- Specialties
- High Content Screening, High Throughput Screening, Stem Cells, Conventional & Automated Electrophysiology, Data Acquisition & Analysis Software, Microplate Readers, Cell Line, Antibody or Protein Development, Label-Free Technologies, Colony Pickers, and Clone Selection
Locations
-
Primary
3860 North First St
San Jose, CA 95134, US
-
Eskdale Road
Wokingham, England RG41 5TS, GB
Updates
-
Day 1 at Festival of Biologics EU is underway! We’re live at Booth 502 as part of the Danaher Corporation Life Sciences booth—alongside SCIEX, Phenomenex, and Genedata—ready to support scientists tackling complex biology. Today’s agenda dives into antibody engineering, cell line development, and automation in biologics workflows. These are exactly the challenges we’re addressing at Molecular Devices. We’re showcasing: The new SpectraMax® iD5e Multi-Mode Microplate Reader, offering five detection modes—absorbance, fluorescence, luminescence, TRF, and FP—to support evolving assay needs. Our application scientist is on-site and ready to demo our QPix® FLEX Microbial Colony Picking System, designed for low-oxygen environments, ideal for microbiome research. Stop by to see how we’re enabling Smart Discovery, Transformative Automation, and Insight Acceleration. 👉 Learn more about our presence at the show: https://lnkd.in/evcC3zPC #FestivalOfBiologics #BiologicsDiscovery #DanaherLifeSciences #MolecularDevices #ColonyPicker #MicroplateReader #AntibodyEngineering #CellLineDevelopment #Automation
-
-
Only one day left to register! If you're working with organoids, spheroids, or tumoroids—or thinking about making the leap into 3D research—this free webinar will show you how automation can help you simplify workflows, improve reproducibility, and scale your research with confidence. Don’t miss the chance to learn practical strategies that could transform how you approach 3D model development. Date: Tuesday, September 30, 2025 Time: 10 AM PDT | 1 PM EDT | 7 PM CEST Register here: https://hubs.la/Q03J7tBz0 #Organoids #Spheroids #LabAutomation #FutureOfCellCulture #PrecisionMedicine
-
-
We’re ready for what’s next Tomorrow marks the start of the Festival of Biologics in Basel – and we cannot wait to unveil our new solutions! We’re proud to be part of the Danaher Corporation booth alongside SCIEX, Phenomenex, and Genedata. 📍 Visit us at Booth 502 to discover how our latest innovations deliver actionable insights! Learn more -> https://lnkd.in/evcC3zPC #FestivalofBiologics #BiologicsDiscovery #MolecularDevices #LifeSciences #Biotech #Pharma #Innovation
-
-
In this Labcompare Q&A, Aaron Risinger of Molecular Devices shares why organoids are redefining how we approach complex biology. Here are six key benefits covered: 1. Human-relevant biology – Organoids recreate tissue architecture and cell-cell interactions that 2D cultures cannot. 2. Ethical innovation – They reduce dependence on animal models while increasing translational accuracy. 3. Quantitative monitoring – High-content imaging provides rich data on growth, morphology, and drug response. 4. Scalability through automation – Manual workflows limit throughput; automation and robotics remove bottlenecks. 5. AI-driven decision-making – Machine learning interprets imaging data to optimize when to feed, passage, or add growth factors during cell culture. 6. The move toward precision medicine – Patient-derived tumoroids enable drug testing tailored to individual biology. Aaron also points to how solutions like the CellXpress .ai Automated Cell Culture System are helping labs automate long-term culture and care of organoids—enabling reproducible, large-scale studies that were once incredibly challenging to perform manually. His perspective highlights the convergence of organoids, automation, and AI as a turning point for discovery and translational science. Read the full article here: https://hubs.la/Q03JpYw_0. #PrecisionMedicine #3DBiology #DrugDiscovery #LabAutomation #Organoids #DanaherNews
-
-
What makes modeling neurodegenerative diseases so challenging? As Dr. Felix Spira explains in his recent Technology Networks Q&A, it comes down to the lack of physiologically relevant model systems: https://hubs.la/Q03KWh0f0. Traditional animal and 2D cell models simply don’t capture the complexity of the human brain, nor do they provide an accurate model for studying the development of conditions like Alzheimer’s and Parkinson’s. Felix draws on his expertise in 3D biology, microscopy, and automation to show how brain organoids are transforming neuroscience. He also highlights how automation is addressing the “storm of challenges” researchers face—manual bottlenecks, inconsistent quality, and lack of standardization. And with innovations like the CellXpress .ai Automated Cell Culture System, scientists now have access to the reproducible models and scalable technology required to push neurodegenerative disease research forward. Read the full article featuring Felix’s insights: https://hubs.la/Q03KWh0f0. #BrainOrganoids #Neurodegeneration #Automation #LifeSciences #DanaherNews #FutureOfCellCulture
-
-
Curious how researchers are scaling 3D cell culture without sacrificing reproducibility? This free webinar will explore how automation is helping labs: – Reduce hands-on time – Improve consistency across experiments – Make smarter, real-time decisions with AI-powered insights Whether you're working with organoids, spheroids, or tumoroids—or just starting to explore 3D models—you’ll walk away with practical strategies to streamline your workflow and accelerate discovery. Date: Tuesday, September 30, 2025 Time: 10 AM PDT | 1 PM EDT | 7 PM CEST Register here: https://hubs.la/Q03J7f0F0 #Organoids #Spheroids #LabAutomation #FutureOfCellCulture #PrecisionMedicine
-
-
Molecular Devices reposted this
Understanding not just 𝘸𝘩𝘪𝘤𝘩 genes are active, but 𝘸𝘩𝘦𝘳𝘦 they’re active inside cells is key to unlocking deeper insights into disease and discovery. In our latest application note, we demonstrate how the ImageXpress HCS .ai High-Content Screening System and AI-powered IN Carta Software enable: ✔️ Reliable single-molecule RNA detection—even for faint signals ✔️ Accurate transcript-to-cell assignment with advanced AI segmentation ✔️ Full-well imaging for comprehensive spatial transcriptomics studies The result? A powerful way to connect gene expression with cell morphology—revealing insights into cancer, neurological disorders, inflammation, and beyond. Download the application note to explore how spatial transcriptomics is advancing complex biological research. 🔗 https://bit.ly/3Kfpt8t #HighContentImaging #SpatialTranscriptomics #DrugDiscovery #DeeperInsightsForEveryLab
-
-
From India to San Jose, Boston to Winnersh, our associates came together for our annual Culture Day—a celebration of the people, traditions, and experiences that make our global community so special. This year’s events brought the world into our offices, with associate-hosted booths showcasing various cultures. From flavorful dishes to lively games and performances—including a Bollywood dance session that had everyone smiling—each experience highlighted the richness and creativity of our teams. Culture Day is more than a single event; it’s a reminder of how powerful shared experiences can be in building connection, understanding, and belonging. Whether stamping “passports” at booths, tasting something new, or simply enjoying conversations, our associates made the day unforgettable.
-
-
Will you be at the Festival of Biologics? Join us along with other Danaher Life Science companies at booth 502 to learn about end-to-end solutions that accelerate drug discovery and development. Our experts are ready to partner with you and discuss how, together, we can accelerate biologics discovery through automation, microbiome research, and therapeutic development. Click here to learn more: https://hubs.la/Q03J8r-V0 See you there!
-